Leerink Partners Cuts Price Target on Alexion Pharma (ALXN) to $216; Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Biotechs Continue to Underperform (IBB)
March 17, 2016 10:28 AM EDTBiotech stocks were pressured Thursday, with NASDAQ Biotechnology Index falling 3%. Weakness outpaced softness in other areas, with Nasdaq composite lower by only 0.45%.
Nasdaq Biotech currently trades at 2537, just north of its year to date low of 2517 -- a level hit on Feb. 11. At that time, Nasdaq traded at... More
